Recursion Pharmaceuticals ( RXRX 1.39%) has been a pioneer in using artificial intelligence (AI) to improve the drug ...

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

I'll walk you through two methods for handling this essential task, plus a third way that achieves total annihilation.

The ability to respond to changing surroundings was once considered exclusive to complex living organisms. Then came ...

A patchwork of internet communities is devoted to the project of ‘awakening’ more digital companions through arcane and enigmatic prompts.

It is certainly possible that today’s bottlenecks will prove to be rather short-lived as companies increasingly learn to ...

The TRM takes a different approach. Jolicoeur-Martineau was inspired by a technique known as the hierarchical reasoning model ...

And while these personas can be generated through most any chatbot, it seems that OpenAI’s 4o model is the origin point and, ...

OpenAI predicts AI will make significant discoveries by 2028, moving beyond chatbots. Learn how AI is set to transform ...

Recursive OS Powered by Symbolic Intelligence Ushers In a New Category of AI Built for Founders, Builders, and Operators Shaping What’s Next ...

AI in Biotechnology Market worth $22,716.5 million by 2035 with 18.5% CAGR | MarketsandMarkets (TM).

In 2026, AI can make very small discoveries but in 2028 and beyond, OpenAI is confident that “we will have systems that can ...